Table 2 : The distribution of responders and non-responders to both therapeutic regimens according the age group among chronic HCV infected patients.

Age group Responders(%) Non-responders(%)
INF  PEG INF INF  PEG INF
ETR SVR ETR SVR ETR SVR ETR SVR
15-34 15 8 42 26 14 21 15 31
35-44 16 8 29 17 11 19 18 30
45-54 9 6 17 4 6 9 6 19
55-84 6 2 10 4 9 13 6 12
Total 46(56.7) 24(34.3) 98(65.8) 51(34.2) 40(39.2) 62(60.8) 45(32.8) 92(67.2)

ETR; end treatment response, SVR; sustained virological response.

A Daw et al.Virology Discovery  2013 1:3DOI : 10.7243/2052-6202-1-3